Recommendations from the European Commission Initiative on Breast Cancer for multigene testing to guide the use of adjuvant chemotherapy in patients with early breast cancer, hormone receptor positive, HER-2 negative

BACKGROUND: Predicting the risk of recurrence and response to chemotherapy in women with early breast cancer is crucial to optimise adjuvant treatment. Despite the common practice of using multigene tests to predict recurrence, existing recommendations are inconsistent. Our aim was to formulate heal...

Descripción completa

Detalles Bibliográficos
Autores principales: Giorgi Rossi, Paolo, Lebeau, Annette, Canelo-Aybar, Carlos, Saz-Parkinson, Zuleika, Quinn, Cecily, Langendam, Miranda, Mcgarrigle, Helen, Warman, Sue, Rigau, David, Alonso-Coello, Pablo, Broeders, Mireille, Graewingholt, Axel, Posso, Margarita, Duffy, Stephen, Schünemann, Holger J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Consensus Statement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076250/
https://www.ncbi.nlm.nih.gov/pubmed/33597715
http://dx.doi.org/10.1038/s41416-020-01247-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076250/
https://www.ncbi.nlm.nih.gov/pubmed/33597715
http://dx.doi.org/10.1038/s41416-020-01247-z

Ejemplares similares